Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8800
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Diagnostic Clinical Services
46.93M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Clinical Services Growth
16.69%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
United States
46.93M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.69%
Log In
Log In
Log In
Log In
Upgrade